Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/174239
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBlanco Arbués, Julià-
dc.contributor.authorSarukhan, Adelaida-
dc.contributor.authorDíez Antón, Juana, 1962--
dc.contributor.authorBassat Orellana, Quique-
dc.contributor.authorCampins Martí, Magda-
dc.contributor.authorGüerri Fernández, Robert-
dc.contributor.authorBrotons, Carlos-
dc.contributor.authorSans Corrales, Mireia-
dc.contributor.authorMiró Meda, José M.-
dc.contributor.authorSanjosé Llongueras, Silvia de-
dc.date.accessioned2021-02-24T11:30:18Z-
dc.date.available2021-02-24T11:30:18Z-
dc.date.issued2021-02-24-
dc.identifier.urihttp://hdl.handle.net/2445/174239-
dc.descriptionAdditional support from ISGlobal’s Antoni Plasència and Josep M. Antó-
dc.description.abstractAs the COVID-19 pandemic progresses, so does our knowledge of the magnitude, type and durability of the immune response to SARS-CoV-2 as a result of natural infection or vaccination. This information is crucial since it will largely define the strategies we need to implement in order to protect individuals and populations. With this in mind, the GCMSC presents its second report, where they review the current knowledge on immunity to SARS-CoV-2 and the implications in terms of public health policies.ca
dc.format.extent37 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoengca
dc.publisherInstitut de Salut Global de Barcelona (ISGlobal)ca
dc.publisherCol·legi Oficial de Metges de Barcelona (COMB)-
dc.rightscc-by (c) Multidisciplinary Collaborative Group for the Scientific Monitoring of COVID-19 (GCMSC), 2021-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceDocuments de treball / Informes (ISGlobal)-
dc.subject.classificationCOVID-19-
dc.subject.classificationVacunes-
dc.subject.classificationImmunitat-
dc.subject.classificationSalut pública-
dc.subject.otherCOVID-19-
dc.subject.otherVaccines-
dc.subject.otherImmunity-
dc.subject.otherPublic health-
dc.titleWhat do we know about Immunity to SARS-CoV-2? Implications for Public Health Policiesca
dc.typeinfo:eu-repo/semantics/reportca
dc.rights.accessRightsinfo:eu-repo/semantics/openAccessca
Appears in Collections:Documents de treball / Informes (ISGlobal)

Files in This Item:
File Description SizeFormat 
Report Immunity to SARS CoV2.pdf668.98 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons